Press Release

Blue California Commercializes Nicotinamide Mononucleotide (NMN) for Supporting an Increased Healthspan

A better cost-effective option is now available for dietary supplement, functional food, and beverage manufacturers. Rancho Santa Margarita, Calif., July 20, 2021 (GLOBE NEWSWIRE) — Blue California joins with the innovative Massachusetts-based biotech company Conagen to announce the commercialization of high-purity, fermentation-derived nicotinamide mononucleotide (NMN). A nature-based metabolic component which has caught the attention of […]

Read more